Toshiaki A. Takahashi
Shizuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 543 publications
Benchmarking Zero-Shot Generative Pre-Trained Transformer-Based Multimodal Large Language Models for Pressure Injury Staging.
Journal: Advances in wound care
Published: July 03, 2026
The Gut Microbiome and Colorectal Cancer: From Association to Causation.
Journal: Cancer biome and targeted therapy
Published: June 29, 2026
The Non-Coding RNA Journal Club: Highlights on Recent Papers-15.
Journal: Non-coding RNA
Published: June 26, 2026
A Case of Solitary Fibrous Tumor with Tumor Rupture during the Waiting Period for Elective Surgery.
Journal: Surgical case reports
Published: June 15, 2026
Artificial intelligence-powered evaluation of the pathologic response to preoperative therapy in non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: May 26, 2026
EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti-Epidermal Growth Factor Receptor-Based Therapy in Metastatic Colorectal Cancer.
Journal: JCO precision oncology
Published: May 18, 2026
A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.
Journal: Future oncology (London, England)
Published: April 27, 2026
Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: safety outcomes from the phase III LAURA study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 06, 2026
Patient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 05, 2026
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
Journal: Thoracic cancer
Published: January 30, 2026
Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study.
Journal: Thoracic cancer
Published: January 27, 2026
Last Updated: 09/26/2026